CRM Spending in the Pharmaceutical Industry 2006-2012
Interactive Model
| Publication Date | June 2007 |
|---|---|
| Publisher | Datamonitor |
| Product Type | Interactive Model |
| Pages | |
| ISBN Number | not applicable |
| Product Code | DAT05878 |
Summary
Introduction
Interactive Model detailing CRM market in Pharmaceuticals (including Big Pharma and Bio Tech) for North America, EMEA and Japan. It is divided into Software and Services from 2006-2012
Reasons to Purchase
- This interactive model will enable you to understand the evolving CRM Pharmaceuticals Market within North America, EMEA and Japan.
- Identify how the structure of the market is going to evolve and how much is spent on different CRM Applications.
Content
Not Available
About this Product
Delivery Details
PDF:Delivered by email usually within 4 to 8 UK business hours.
Related Products
- AstraZeneca’s Crestor Could Revolutionise Heart Disease Treatment >>
- Sanofi-Aventis and Pfizer Stop Development of a Class of Anti-obesity drugs >>
- Pharma Companies turn Webwards to Recruit Patients as 90% of Clinical Trials Face Delay >>
- Have your Healthcare Costs Reduced with Personalized Healthcare >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Chemicals
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Market Publishers
Meet Us
Jobs
Contact Us
Categories and Subcategories















